Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

plecanatide

plecanatide
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Trulance TABLET, ORAL 3 mg    


Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

plecanatide (Trulance)

  • 3 mg PO tablet daily

linaCLOtide (Linzess)

  • 145 mcg PO tablet daily

Restricted to no substitution orders.  No substitution can be specified by pharmacist to facilitate enteral administration (may be crushed) via G tubes.

 

Patient may use home supply during inpatient stay if desired.


Reviewed: 22 Aug 2017 (Trulance)


Last updated: Sep. 3, 2020
  • Formulary, Not Routinely Stocked: Trulance --> 3 mg tablet







This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.